Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America

  • Yohei Doi
  • , Jennifer M. Adams
  • , Kunikazu Yamane
  • , David L. Paterson

Research output: Contribution to journalArticlepeer-review

Abstract

Five highly amikacin-resistant Acinetobacter baumannii isolates were collected at a medical center in Pennsylvania. The aminoglycoside resistance was due to the production of the 16S rRNA methylase ArmA. Two of the isolates coproduced OXA-23 β-lactamase and were highly resistant to carbapenems as well. The isolates were genetically closely related by pulsed-field gel electrophoresis.

Original languageEnglish
Pages (from-to)4209-4210
Number of pages2
JournalAntimicrobial agents and chemotherapy
Volume51
Issue number11
DOIs
Publication statusPublished - 11-2007
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America'. Together they form a unique fingerprint.

Cite this